AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 10 124 GBX -1.27%
Market Cap: 157B GBX

Intrinsic Value

The intrinsic value of one AZN stock under the Base Case scenario is 12 983.69 GBX. Compared to the current market price of 10 124 GBX, AstraZeneca PLC is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AZN Intrinsic Value
12 983.69 GBX
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AstraZeneca PLC

AZN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AZN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

AstraZeneca PLC
LSE:AZN
UK
Pharmaceuticals
Market Cap
157B GBX
IPO
Sep 21, 2007
UK
Pharmaceuticals
Market Cap
157B GBX
IPO
Sep 21, 2007
Price
gbxfalse
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AZN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about AstraZeneca PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
AstraZeneca PLC

Current Assets 25.8B
Cash & Short-Term Investments 5.7B
Receivables 14.8B
Other Current Assets 5.3B
Non-Current Assets 78.2B
Long-Term Investments 1.9B
PP&E 11.6B
Intangibles 58.2B
Other Non-Current Assets 6.5B
Efficiency

Free Cash Flow Analysis
AstraZeneca PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AstraZeneca PLC

Revenue
54.1B USD
Cost of Revenue
-9.7B USD
Gross Profit
44.4B USD
Operating Expenses
-31.7B USD
Operating Income
12.7B USD
Other Expenses
-5.6B USD
Net Income
7B USD
Fundamental Scores

AZN Profitability Score
Profitability Due Diligence

AstraZeneca PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROE is Increasing
Positive 3-Years Revenue Growth
62/100
Profitability
Score

AstraZeneca PLC's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

AZN Solvency Score
Solvency Due Diligence

AstraZeneca PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
48/100
Solvency
Score

AstraZeneca PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AZN Price Targets Summary
AstraZeneca PLC

Wall Street analysts forecast AZN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AZN is 14 189.21 GBX with a low forecast of 6 864.74 GBX and a high forecast of 19 950 GBX.

Lowest
Price Target
6 864.74 GBX
32% Downside
Average
Price Target
14 189.21 GBX
40% Upside
Highest
Price Target
19 950 GBX
97% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AZN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AZN Insider Trading
Buy and sell transactions by insiders

AZN News

Other Videos
What is the Intrinsic Value of one AZN stock?

The intrinsic value of one AZN stock under the Base Case scenario is 12 983.69 GBX.

Is AZN stock undervalued or overvalued?

Compared to the current market price of 10 124 GBX, AstraZeneca PLC is Undervalued by 22%.

Back to Top